DEKA

Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

Retrieved on: 
Monday, March 18, 2024

MANCHESTER, N.H., March 18, 2024 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the innovative twiist™ Automated Insulin Delivery (AID) system powered by Tidepool.

Key Points: 
  • MANCHESTER, N.H., March 18, 2024 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the innovative twiist™ Automated Insulin Delivery (AID) system powered by Tidepool.
  • The twiist AID system, which will be commercialized by Sequel Med Tech, LLC, is the first drug delivery system that directly measures the volume and flow of insulin delivered with every micro-dose.
  • “The clearance of the twiist AID system is a pivotal first step in Sequel’s quest to make day-to-day life easier for people with type 1 diabetes.
  • The twiist system was designed from the start to integrate with the latest available innovation, and it represents the next generation of insulin delivery,” said Kamen.

Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex’s Immunotherapeutic Candidates with DEKA’s Intradermal Therapeutic Applicator

Retrieved on: 
Tuesday, January 16, 2024

Emergex has entered into an agreement with DEKA Research & Development (‘DEKA’) to assess the compatibility of Emergex’s T cell-priming set-point immunotherapeutic candidates with DEKA’s Intradermal Therapeutic Applicator.

Key Points: 
  • Emergex has entered into an agreement with DEKA Research & Development (‘DEKA’) to assess the compatibility of Emergex’s T cell-priming set-point immunotherapeutic candidates with DEKA’s Intradermal Therapeutic Applicator.
  • The collaboration builds on previous data showing satisfactory loading and stability of Emergex’s therapeutic candidates when incorporated with the Intradermal Therapeutic Applicator.
  • This agreement builds on previous data showing satisfactory loading and stability of Emergex’s product candidates when incorporated into the Intradermal Therapeutic Applicator.
  • Dean Kamen, Founder and President, of DEKA Research & Development, commented: “The partnership with Emergex is a meaningful step forward in patient therapeutic delivery.

2023 Advantech Embedded-IoT World Partner Conference

Retrieved on: 
Friday, December 8, 2023

TAIPEI, Dec. 7, 2023 /PRNewswire/ -- A global leader in embedded markets, hosted the Embedded-IoT World Partner Conference from Nov 30 to Dec 2 at Advantech's AIoT Co-Creation Campus. The conference gathered over 500 attendees from more than 40 countries and revolved around the key theme: Edge Evolution – Shaping the Future of Embedded and Emerging Business. The conference covered a wide range of topics, featuring over 80 solution showcases launched simultaneously. Additionally, 56+ guest speakers were invited to deliver lectures during the event, offering diverse insights into the AIoT industry.

Key Points: 
  • TAIPEI, Dec. 7, 2023 /PRNewswire/ -- A global leader in embedded markets, hosted the Embedded-IoT World Partner Conference from Nov 30 to Dec 2 at Advantech's AIoT Co-Creation Campus.
  • The conference gathered over 500 attendees from more than 40 countries and revolved around the key theme: Edge Evolution – Shaping the Future of Embedded and Emerging Business.
  • The conference covered a wide range of topics, featuring over 80 solution showcases launched simultaneously.
  • Through collaboration with global sales channels and distribution partners, Advantech aims to enter emerging domains such as EV infrastructure, robotics, and AMR.

Dr. Jason Choorapuzha Introduces Innovative Rapid Snoring Solution

Retrieved on: 
Friday, August 25, 2023

With his recent training in DEKA QuietNite, a state-of-the-art soft tissue application, Dr. Choorapuzha is now equipped to provide rapid relief from snoring in under 10 minutes.

Key Points: 
  • With his recent training in DEKA QuietNite, a state-of-the-art soft tissue application, Dr. Choorapuzha is now equipped to provide rapid relief from snoring in under 10 minutes.
  • DEKA QuietNite is a non-invasive, painless, quiet, and quick procedure utilizing CO2 energy to target the tissues that cause snoring.
  • By gently addressing the underlying causes of snoring: loss of soft palate elasticity and reduced throat volume, this innovative treatment improves the quality of sleep without significant downtime or discomfort.
  • Understanding the detrimental effects of snoring on sleep quality and overall health, Dr. Choorapuzha emphasizes the importance of addressing this issue.

Lumaflex is Ready to "Lumanate" DEKA FIT Events with Red Light Therapy in New Partnership with Spartan Brand

Retrieved on: 
Thursday, August 17, 2023

MINNEAPOLIS, Aug. 17, 2023 /PRNewswire/ -- Lumaflex, a healthtech startup that has developed the world's first FDA-cleared portable, flexible, waterproof red light therapy device, has announced a new partnership with DEKA FIT by Spartan, one of the most well-known event-driven brands in fitness. Lumaflex will have a presence at upcoming DEKA FIT events to showcase its new Lumaflex Body Pro unit, and help bring the benefits of red light therapy to the DEKA FIT fitness community.

Key Points: 
  • At each of these DEKA events, DEKA FIT athletes can experience Lumaflex and try the Lumaflex Body Pro unit in-person.
  • DEKA FIT by Spartan is the indoor "dekathlon" of fitness, with indoor fitness competitions and motivational training for people at all levels.
  • DEKA also has a national network of affiliate gyms that meet DEKA standards and contribute teams to participate at local and regional DEKA FIT events.
  • Lumaflex Body Pro is the world's first FDA-cleared portable, flexible, waterproof red light therapy solution for personal, targeted red light therapy.

Now Available: Experiential Robotics Platform (XRP) Kit - Beta, the Premier Introduction to Robotics and STEM

Retrieved on: 
Thursday, July 6, 2023

BOULDER, Colo., July 6, 2023 /PRNewswire/ -- A consortium of leading educators and technology companies have announced the release of the XRP Kit - Beta, an entry-level open-source robotics ecosystem intended to expand global participation in robotics, inspire future engineers, and serve as a springboard for STEM education for grades 8-12, electronics beginners, and robotics enthusiasts of any age. As of today, anyone can preorder the XRP Kit through SparkFun® or DigiKey®.

Key Points: 
  • As of today, anyone can preorder the XRP Kit through SparkFun® or DigiKe y® .
  • This group has ensured a pricing structure that offers educators a 43% discount to significantly increase accessibility.
  • "This hands-on platform, combined with the WPI OpenSTEM curriculum, educational resources, and online community support, will help educators inspire future innovators and technology leaders."
  • "At FIRST, we provide life-changing robotics programs that give young people the skills, confidence, and resilience to build a better world.

Truvian Health to Present Performance of Blood Testing Solution from Recent Multisite Clinical Study at the American Association of Clinical Chemistry Annual Scientific Meeting

Retrieved on: 
Wednesday, June 28, 2023

“Chronic diseases account for 41 million deaths each year – 74% of deaths globally – and present a significant cost burden that forces millions into poverty1.

Key Points: 
  • “Chronic diseases account for 41 million deaths each year – 74% of deaths globally – and present a significant cost burden that forces millions into poverty1.
  • As a result, we can reduce the time from blood draw results for an expansive panel of tests – quickly providing actionable insights where and when they are needed.
  • With an initial testing panel of more than 30 assays, the Truvian Platform can run the most commonly ordered tests that account for 90% of blood test orders.
  • To continue to advance the Truvian Platform, currently in late-stage development, the company recently expanded its advisory board.

Dr. Jason Choorapuzha of Connections Dental Enhances Dental Practice with Advanced Laser Training in Italy

Retrieved on: 
Friday, June 16, 2023

This exciting development brings new and innovative laser treatments to his practice; benefiting patients with enhanced precision, comfort, and effectiveness.

Key Points: 
  • This exciting development brings new and innovative laser treatments to his practice; benefiting patients with enhanced precision, comfort, and effectiveness.
  • The CO2 laser, handcrafted in Italy, is renowned worldwide for its versatility and exceptional performance in various medical fields.
  • Dr. Choorapuzha is proud to bring this state-of-the-art laser technology to his dental practice, allowing patients to experience the advantages of advanced laser treatments.
  • "We are excited to share the new and advanced laser technology we recently added to the practice to benefit our patients," said Dr. Choorapuzha.

Cartessa Aesthetics Introduces Helix by DEKA, a Powerful Fusion of Skin Resurfacing Technology

Retrieved on: 
Tuesday, May 23, 2023

MELVILLE, N.Y., May 23, 2023 /PRNewswire/ -- In the growing category of non-invasive, energy-based aesthetic procedures, laser skin resurfacing occupies one of the largest shares.  Laser resurfacing is an effective way to reduce the appearance of fine lines, wrinkles, scars, unwanted pigment, and improve skin's tone and texture. Cartessa Aesthetics and its manufacturing partner, DEKA, have been at the forefront of skin resurfacing innovation in North America and today introduces the newest resurfacing innovation HELIX - advanced fractional ablative CO2 and non-ablative technologies in one device.

Key Points: 
  • Cartessa Aesthetics and its manufacturing partner, DEKA, have been at the forefront of skin resurfacing innovation in North America and today introduces the newest resurfacing innovation HELIX - advanced fractional ablative CO2 and non-ablative technologies in one device.
  • Helix delivers an optimal patient experience with three branded protocols: CoolPeel, Sultra, and unique combination resurfacing treatment Fusion.
  • Only Helix's Fusion can combine three CO2 pulse shapes with non-ablative in variable mixed modes and depths for exceptional skin resurfacing customization.
  • Dr. Mark Halsey, owner and lead physician at Halsey Dermatology in Sag Harbor, NY states, "The Helix is a skin resurfacing dream.

Revolutionary and Affordable New Robotics System Makes Debut at 2022 FIRST Global Challenge = A Win for STEM Equity

Retrieved on: 
Thursday, October 13, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221013005815/en/
    WPI and DEKA developed the XRP robot to be a game changer in STEM education.
  • Simple, tool-free assembly allows for a quick build and parts can be replaced easily with the use of a 3-D printer.
  • (17.78 cm by 12.7 cm, .45 km) -about the size of a box of chocolates-will cost less than $50.
  • All 185 teams representing 180 nations at this years FIRST Global Challenge are given a free XRP to bring back to their home countries.